The upscheduling of combination analgesics containing codeine: The impact on the practice of pharmacists

Research in Social and Administrative Pharmacy

Volumn 10, Issue 4, 2014, Pages 669-678

  Hamer, Ainslie M ^a   Spark, M Joy ^a   Wood, Penelope J ^a   Roberts, Emily ^b  

^a La Trobe Institute of Molecular Science (LIMS)   (Australia)

^b Emily Roberts Pharmacy   (Australia)

Author keywords

Codeine containing analgesic; Community pharmacists; Pharmacist Only Medicines; Pharmacy practice

Indexed keywords

ANALGESIC AGENT; CODEINE; DRUG COMBINATION;

ADULT; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; TRENDS;

ADULT; ANALGESICS; CODEINE; COMMUNITY PHARMACY SERVICES; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; PROFESSIONAL ROLE;

EID: 84904093803     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2013.08.004     Document Type: Article

References (34)

1. Reed K., Bond A., Witton J., et al. The Changing Use of Prescribed Benzodiazepines and z-drugs and of Over-the-counter Codeine-containing Products in England: A Structured Review of Published English and International Evidence and Available Data to Inform Consideration of the Extent of Dependence and Harm 2011, The National Addiction Centre, Kings College London, London, Available at:, Accessed 11.10.12. http://www.appgita.com/wp-content/uploads/2011/05/Report-1-NAC-Benzos-and-z-drug-addiction.pdf.
2. Nielsen S., Tobin C., Dobbin M. OTC codeine: examining the evidence for and against. Aust Pharm 2012, 31:236-240.
3. McDonough M.A. Misuse of codeine-containing combination analgesics. Med J Aust 2011, 194:486.
4. Frei M.Y., Nielsen S., Dobbin M.D.H., et al. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust 2010, 193:294-296.
5. Daly F.F.S., Fountain J.S., Murray L., et al. Guidelines for the management of paracetamol poisoning in Australia and New Zealand - explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust 2008, 188:296-301.
6. Chetty R., Baoku Y., Mildner R., et al. Severe hypokalaemia and weakness due to Nurofen misuse. Ann Clin Biochem 2003, 40:422-423.
7. Dutch M.J. Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. Med J Aust 2008, 188:56-57.
8. Dyer B.T., Martin J.L., Mitchell J.L., et al. Hypokalaemia in ibuprofen and codeine phosphate abuse. Int J Clin Pract 2004, 58:1061-1062.
9. Ernest D., Chia M., Corallo C.E. Profound hypokalaemia due to Nurofen Plus and Red Bull misuse. Crit Care Resusc 2010, 12:109-110.
10. Lambert A.P., Close C. Life-threatening hypokalaemia from abuse of Nurofen Plus. J R Soc Med 2005, 98:21.
11. The Pharmacy Guild of Australia. Australia's Unique Medication Scheduling System. Available at: ; Accessed 29.09.12. http://www.guild.org.au/iwov-resources/documents/The_Guild/PDFs/News%20and%20Events/Publications/Fact%20Sheets/scheduling_system.pdf.
12. Tan A.C.W., Emmerton L. Non-prescription medicines: current issues in Australian community pharmacy. Int J Pharm Pract 2009, 17:207-213.
13. Norris P.T. New Zealand pharmacists and pharmacist-only medicines. J Pharm Pract Res 2004, 34:282-284.
14. Therapeutic Goods Administration. Codeine Rescheduling - Information for Sponsors. Availableat: ; Accessed 06.10.12. http://www.tga.gov.au/industry/otc-codeine-rescheduling-100224.htm.
15. Hanna L., Hughes C.M. First, do no harm: factors that influence pharmacists making decisions about over-the-counter medication: a qualitative study in Northern Ireland. Drug Saf 2010, 33:245-255.
16. Akram G., Roberts K. Pharmacists management of over-the-counter medication requests from methadone patients. J Subst Use 2003, 8:215-222.
17. MacFayden L., Eadie D., McGowan T. Community pharmacists' experience of over-the-counter medicine misuse in Scotland. J R Soc Promot Health 2001, 121:185-192.
18. Wazaify M., Hughes C.M., McElnay J.C. The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland. Patient Educ Couns 2006, 64:136-141.
19. Nielsen S., Cameron J., Sanja P. Over the Counter Codeine Dependence Final Report 2010 2010 Jun, Turning Point Alcohol & Drug Centre, Fitzroy, VIC, Available at:, Accessed 11.10.12. http://atdc.org.au/wpcontent/uploads/2011/02/OTC_CODEINE_REPORT.pdf.
20. McBride A.J., Pates R., Ramadan R., et al. Delphi survey of experts' opinions on strategies used by community pharmacists to reduce over-the-counter drug misuse. Addiction 2003, 98:487-497.
21. Albsoul-Younes A., Wazaify M., Yousef A., et al. Abuse and misuse of prescription and nonprescription drugs sold in community pharmacies in Jordan. Subst Use Misuse 2010, 45:1319-1329.
22. Smith F.J. Conducting Your Pharmacy Research Project 2005, Pharmaceutical Press, London.
23. Crosby R.A., DiClemente R.J., Salazar L.F. Research Methods in Health Promotion 2006, Jossey-Bass, San Francisco, CA.
24. Neergaard M.A., Olesen F., Andersen R.S., et al. Qualitative description - the poor cousin of health research?. BMC Med Res Methodol 2009, 9:52-56.
25. Carlson J.A. Avoiding traps in member checking. Qual Rep 2010, 15:1102-1113.
26. The Pharmacy Guild of Australia. Project Stop. Available at: ; Accessed 06.10.12. http://www.projectstop.com/.
27. Australian Pharmaceutical Formulary and Handbook 2012, Pharmaceutical Society of Australia, Canberra, ACT. 22nd ed. L.N. Sansom (Ed.).
28. Sproule B.A. Decreasing the harms of prescription opioids: a case for pharmacists. Drug Alcohol Rev 2011, 30:327-329.
29. Lafferty L., Hunter T.S., Marsh W.A. Knowledge, attitudes and practices of pharmacists concerning prescription drug abuse. J Psychoactive Drugs 2006, 38:229.
30. Morris C.J., Cantrill J.A., Weiss M.C. "One simple question should be enough": consumers' perceptions of pharmacy protocols. Int J Pharm Pract 1997, 5:64-71.
31. Hughes C.M., McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract 2003, 53:600-606.
32. Carter B.L., Bergus G.R., Dawson J.D., et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J Clin Hypertens (Greenwich) 2008, 10:260-271.
33. Ramser K.L., Sprabery L.R., George C.M., et al. Physician-pharmacist collaboration in the management ofpatients with diabetes resistant to usual care. Diabetes Spectr 2008, 21:209-214.
34. Benavides S., Rodriguez J.C., Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother 2009, 43:85-97.